Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared Shebli Atrash’s, Oncologist at Levine Cancer Institute, post on LinkedIn, adding:
“Outstanding work Shebli Atrash and Barry Paul”
Quoting Shebli Atrash’s post:
“Join us for the National ICE-T Conference! Prominent doctors leading the future of immunotherapy.”
Other articles featuring Al-Ola Abdallah and Shebli Atrash on OncoDaily.
